StockData
AbbVie Inc. logo

AbbVie Inc. (ABBV) operating KPIs

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$294.89+4.10 (+1.41%)

Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%

AbbVie eye Care Portfolio [folded into All Other in Q1 2026] — Worldwide net revenues ($M) ($M)

Form 10-Q / 10-K Segment & Revenue Disaggregation Note & Form 8-K Key Product Revenues

QuarterlyAnnual
Latest, FY2025
2,109
Period ended Dec 31, 2025
Change on a year earlier
-5.9%
2,242 in FY2024
History
6 years
Since FY2020
Sources
6
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedEye Care Portfolio [folded into All Other in Q1 2026] — Worldwide net revenues ($M) ($M)Year on yearSource
FY2025Dec 31, 20252,109-5.9%Form 8-K (abbv-20251231xexhibit991.htm, filed 2026-02-04) ↗
FY2024Dec 31, 20242,242-7.2%Form 8-K (abbv-20241231xexhibit991.htm, filed 2025-01-31) ↗
FY2023Dec 31, 20232,415-10.6%Form 8-K (abbv-20231231xexhibit991.htm, filed 2024-02-02) ↗
FY2022Dec 31, 20222,701-24.3%Form 8-K (abbv-20221231xexhibit991.htm, filed 2023-02-09) ↗
FY2021Dec 31, 20213,567+63.3%Form 8-K (abbv-20211231xexhibit991.htm, filed 2022-02-02) ↗
FY2020Dec 31, 20202,184–Form 8-K (abbv-20201231xexhibit991.htm, filed 2021-02-03) ↗

Breakdown

What makes up eye care portfolio [folded into all other in q1 2026] — worldwide net revenues ($m)

Cite this data

StockData. (2026). AbbVie Eye Care Portfolio [folded into All Other in Q1 2026] — Worldwide net revenues ($M) ($M), annual FY2020–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/ta_eye_ww

See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.